
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Rab11-FIP3 CRISPR/Cas9 KO Plasmid (h) | sc-405735 | 20 µg | $397.00 |
RAB11FIP3 encodes Rab11 family-interacting protein 3 (Rab11-FIP3), a Rab11 effector that coordinates recycling endosome function and membrane trafficking during cytokinesis. Rab11-FIP3 helps direct endocytic recycling and vesicle targeting to the midbody, supporting abscission and proper cell-cycle progression, and it interfaces with RAB11-dependent transport routes that shape receptor recycling and polarity. Through its role in recycling endosome dynamics, Rab11-FIP3 contributes to processes that influence cell migration and proliferation, making it relevant to studies of dysregulated trafficking in cancer-associated phenotypes. Altered expression or functional perturbation of Rab11-FIP3 has also been linked to defects in cell division and membrane remodeling pathways that can impact genomic stability.
Rab11-FIP3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the RAB11FIP3 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the RAB11FIP3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the RAB11FIP3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Rab11-FIP3 protein expression.
This CRISPR knockout system enables efficient generation of RAB11FIP3-deficient cell models for investigation of Rab11-FIP3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.